Cite
Development and Validation of a Capillary Zone Electrophoresis–Tandem Mass Spectrometry Method for Simultaneous Quantification of Eight β-Lactam Antibiotics and Two β-Lactamase Inhibitors in Plasma Samples.
MLA
Cizmarova, Ivana, et al. “Development and Validation of a Capillary Zone Electrophoresis–Tandem Mass Spectrometry Method for Simultaneous Quantification of Eight β-Lactam Antibiotics and Two β-Lactamase Inhibitors in Plasma Samples.” Pharmaceuticals (14248247), vol. 17, no. 4, Apr. 2024, p. 526. EBSCOhost, https://doi.org/10.3390/ph17040526.
APA
Cizmarova, I., Mikus, P., Svidrnoch, M., & Piestansky, J. (2024). Development and Validation of a Capillary Zone Electrophoresis–Tandem Mass Spectrometry Method for Simultaneous Quantification of Eight β-Lactam Antibiotics and Two β-Lactamase Inhibitors in Plasma Samples. Pharmaceuticals (14248247), 17(4), 526. https://doi.org/10.3390/ph17040526
Chicago
Cizmarova, Ivana, Peter Mikus, Martin Svidrnoch, and Juraj Piestansky. 2024. “Development and Validation of a Capillary Zone Electrophoresis–Tandem Mass Spectrometry Method for Simultaneous Quantification of Eight β-Lactam Antibiotics and Two β-Lactamase Inhibitors in Plasma Samples.” Pharmaceuticals (14248247) 17 (4): 526. doi:10.3390/ph17040526.